Retraction: The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer

Hong Wang¹, Chunlei Wang², Wenling Tian¹ and Yanfen Yao³

¹Department of General Surgery, Shandong Provincial Third Hospital, Jinan, Shandong, China
²Thyroid Disease Prevention and Control Center, Shandong Provincial Institute of Endemic Disease Control, Jinan, Shandong, China
³Department of Intensive Care Unit, Shandong Provincial Third Hospital, Jinan, Shandong, China

Published: August 14, 2024

This article has been retracted: Figure 1C, presenting IHC staining for SRPK1 in gastric cancer tissues, contains a duplicate image of Figure 1C illustrating IHC staining for neogenin-1 in adjacent normal tissues of gastric cancer, from a previously published paper [1]. Figure 7B, presenting images of wound healing assay in gastric cancer cells, also contains a duplicate image from Figure 3A in a second previously published paper [2], studying epithelial ovarian carcinoma. And images of transwell assay In Figure 7C, are duplicates of images from Figure 6B and 6D in a third earlier published paper describing hepatocellular carcinoma study [3]. In light of these facts, the Editorial decision has been made to retract this paper. All authors agreed with the decision.

REFERENCES

1. Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH. Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer. Oncotarget. 2014; 5:3386–98. https://doi.org/10.18632/oncotarget.1960. [PubMed].
2. Cheng S, Guo J, Yang Q, Han L. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas. Tumour Biol. 2015; 36:915–19. https://doi.org/10.1007/s13277-014-2724-0. [PubMed].
3. Sui C, Zhuang C, Sun D, Yang L, Zhang L, Song L. Notch1 regulates the JNK signaling pathway and increases apoptosis in h lular carcinoma. Oncotarget. 2017; 8:45837–47. https://doi.org/10.18632/oncotarget.17434. [PubMed].

Original article: Oncotarget. 2017; 8:72157–72166. DOI: https://doi.org/10.18632/oncotarget.20048